Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Plos One|January 24, 2025
Correction: High prevalence of p16 staining in malignant tumorsNoémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Biomarker Research|December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samplesSeyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology|January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entitiesFlorian Viehweger, Carola Böcker, Sören Weidemann, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
The American Journal of Surgical Pathology|January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the PancreasMaximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 17, 2024
Staining pattern of specific and cross-reacting Melan-A antibodies: A comparative study on 15,840 samples from 133 human tumor typesShiva Boroojerdi, Sören Weidemann, Anne Menz, et al.
Cancer Medicine|November 13, 2024
Prevalence and Significance of AGR2 Expression in Human CancerNina Schraps, Jacob Constantin Port, Anne Menz, et al.
Acta Oncologica (Stockholm, Sweden)|June 7, 2021
High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancerKatharina Möller, Niclas C Blessin, Doris Höflmayer, et al.
Pageof 17